Page 7 - 762 News Today : Breaking News, Live Updates & Top Stories | Vimarsana

See in 27 states with midwestern states accounting for more than a third of new infections. and hospitalizations are starting to pick up in the united states as well. and that is all leading to growing concerns of a winter surge. the centers for disease control and prevention said so far only about a quarter of eligible adults have received a booster shot. well, next week advisers with the u.s. food and drug administration will meet to discuss a new antiviral pill to treat early stage covid cases. the pharmaceutical company merck says early data shows its pill reduce i hospitalizations and d...

Covid-19, but there are also some safety concerns. senior medical correspondent elizabeth cohen is joining us now with new cnn reporting. what are these safety concerns, elizabeth? >> so, brianna, when the fda advisers meet one week from today to look at merck's anti-viral pill, they'll be looking at efficacy and safety. i think there's going to be more discussion about safety. that's really because the efficacy is, as one doctor put it to me, quite dramatic. let's look at efficacy, then we'll talk about the safety in a sec. 762 participants, early stage covid, first five days of symptom onset...

Also concerns would this okay for developing fetuses? is it possible that if it messes with the viruses' genetic material might it affect the genetic material of a developing fetus so there would be discussion about whether it's appropriate for pregnant women to take the pill but to get back to the f-fassie let's take a look at what the clinical trials found. they looked at 762 clinical trial participants. half got a placebo, a pill that did did nothing. over a month 45 ended up in the hospital and nine of them died. of those who got the drug, 28 got hospitalized and zero died. remember, this ...

Filling u.s. hospitals. merck says clinical trials for its pill reduced covid hospitalizations and death by almost 50%. while some doctors say those results are impressive, others are raising red flags. let's bring in cnn's elizabeth cohen. elizabeth, let's start with what doctors and scientists are seeing in these trials that's so impressive. >> doctors have described these results as dramatic and as you said, impressive. let's take a look at these numbers. so merck, which owns this antiviral, merck did a clinical trial with 762 participants. half of them got a placebo over the course of abou...

I'm talking early stage covid, not in the hospital, but they're tricky to administer. there are monoclonal ant bibodi, and this would be easier if doctors could prescribe a pill, call it into the pharmacy for those with early symptoms. merck has put it out in a press release. it's not been published or peer reviewed. they said they had a clinical trial of 762 participants, again, early stage covid, not in the hospital, and half of them got a placebo, a pill that does nothing. of those folks when they followed them, 45 ended up in the hospital and 8 died. the folk who is got the actual antivira...